Doravirine for Obese Persons on Integrase Inhibitors and Tenofovir Alafenamide
Public ClinicalTrials.gov record NCT04636437. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Doravirine for Obese Persons on Integrase Inhibitors and Tenofovir Alafenamide (The Do IT Study)
Study identification
- NCT ID
- NCT04636437
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Network
- Enrollment
- 147 participants
Conditions and interventions
Conditions
Interventions
- Doravirine 100 Mg Drug
- Integrase strand transfer inhibitors Drug
- Tenofovir alafenamide/emtricitabine Drug
- tenofovir disproxil fumarate/emtricitabine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 26, 2021
- Primary completion
- Oct 17, 2024
- Completion
- Oct 17, 2024
- Last update posted
- Jul 1, 2025
2021 – 2024
United States locations
- U.S. sites
- 27
- U.S. states
- 17
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama CRS (31788) | Birmingham | Alabama | 35294 | — |
| UCLA CARE Center CRS (601) | Los Angeles | California | 90095 | — |
| UCSD Antiviral Research Center CRS (701) | San Diego | California | 92103 | — |
| Ucsf Hiv/Aids Crs (801) | San Francisco | California | 94110 | — |
| Harbor-UCLA CRS (603) | Torrance | California | 90502 | — |
| University of Colorado Hospital CRS (6101) | Aurora | Colorado | 80045 | — |
| Whitman-Walker Institute, Inc. CRS (31791) | Washington D.C. | District of Columbia | 20005 | — |
| The Ponce de Leon Center CRS (5802) | Atlanta | Georgia | 30308 | — |
| Northwestern University CRS (2701) | Chicago | Illinois | 60611 | — |
| Johns Hopkins University CRS (201) | Baltimore | Maryland | 21205 | — |
| Massachusetts General Hospital (MGH) CRS (101) | Boston | Massachusetts | 02114 | — |
| Brigham and Women's Hosp. ACTG CRS (107) | Boston | Massachusetts | 02115 | — |
| Washington University Therapeutics (WT) CRS (2101) | St Louis | Missouri | 63110 | — |
| New Jersey Medical School Clinical Research Center CRS (31786) | Newark | New Jersey | 07103 | — |
| Weill Cornell Chelsea CRS (7804) | New York | New York | 10010 | — |
| Columbia Physicians and Surgeons (P&S) CRS (30329) | New York | New York | 10032 | — |
| Weill Cornell Upton CRS (7803) | New York | New York | 10065 | — |
| University of Rochester Adult HIV Therapeutic Strategies Network CRS (31787) | Rochester | New York | 14642 | — |
| Chapel Hill CRS (3201) | Chapel Hill | North Carolina | 27514 | — |
| Greensboro CRS (3203) | Greensboro | North Carolina | 27401 | — |
| Cincinnati CRS (2401) | Cincinnati | Ohio | 45267 | — |
| Case CRS (2501) | Cleveland | Ohio | 44106 | — |
| Ohio State University CRS (2301) | Columbus | Ohio | 43210 | — |
| Penn Therapeutics CRS (6201) | Philadelphia | Pennsylvania | 19104 | — |
| Vanderbilt Therapeutics (VT) CRS (3652) | Nashville | Tennessee | 37204 | — |
| Houston AIDS Research Team CRS (31473) | Houston | Texas | 77030 | — |
| University of Washington Positive Research CRS (1401) | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04636437, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2025 · Synced Jul 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04636437 live on ClinicalTrials.gov.